Share
Other content recommended for you
- Granulocyte activation markers in cerebrospinal fluid differentiate acute neuromyelitis spectrum disorder from multiple sclerosis
- Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease
- Autocrine MMP-2/9 secretion increases the BBB permeability in neuromyelitis optica
- Ring-enhancing spinal cord lesions in neuromyelitis optica spectrum disorders
- Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders
- A practical approach to the diagnosis of spinal cord lesions
- Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination
- Silent progression of brain atrophy in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder
- No evidence of misdiagnosis in patients with multiple sclerosis and repeated positive anticardiolipin antibody testing based on magnetic resonance imaging and long term follow-up
- Neurodegeneration in multiple sclerosis and neuromyelitis optica